From step Counters to Clinical Tools: How Wearables Are Maturing into VBC Infrastructure

As VBC continues to gain traction, the role of biometric wearables is transforming. What began as consumer tech is 𝘣𝘦𝘤𝘰𝘮𝘪𝘯𝘨 𝘧𝘰𝘶𝘯𝘥𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘵𝘰 𝘳𝘪𝘴𝘬-𝘣𝘢𝘴𝘦𝘥 𝘤𝘢𝘳𝘦 𝘮𝘰𝘥𝘦𝘭𝘴.

Wearables are now being integrated into clinical protocols for:

▪️ Chronic disease management

▪️ Behavioral health

▪️ Post-acute monitoring

▪️ Decentralized trials

They provide continuous, passive data capture that supports proactive intervention. Traditional episodic care lacks this kind of real-time visibility, which is increasingly critical to reducing utilization, improving adherence, and enhancing outcomes under VBC contracts.

HHS has signaled that real-time patient monitoring is a national priority, given its potential to improve health outcomes and support care delivery in both rural and underserved settings.

For early-stage companies, expectations now require:

Clinical validation

EMR integration

Scalable patient engagement

Reimbursement readiness

Strategics and investors focus on platforms that align with value-based economics and can demonstrate measurable impact on cost and quality.

At our firm, we view this convergence as one of the most investable areas in healthcare innovation. If you're a founder building sensing and monitoring platforms, we would welcome a conversation.

Previous
Previous

FDA Policy Shift: Implications for MedTech & Diagnostics

Next
Next

DealScape | AI in Medtech